• SPX
  • $5,751.07
  • 0.9 %
  • $51.13
  • DJI
  • $42,352.75
  • 0.81 %
  • $341.16
  • N225
  • $38,635.62
  • 0.22 %
  • $83.56
  • FTSE
  • $8,280.63
  • -0.02 %
  • -$1.89
  • IXIC
  • $18,137.85
  • 1.22 %
  • $219.38
Y-mAbs Therapeutics, Inc. (YMAB) Earning

Y-mAbs Therapeutics, Inc. (YMAB) Earning

NASDAQ Currency in USD Disclaimer

Stock Price

$14.05

$0.53

(3.92%)

Day's range
$13.44
Day's range
$14.22

Y-mAbs Therapeutics, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 3 -$0.14 -$0.14 -$0.14
Q2 2024 2 -$0.12 -$0.12 -$0.12
Q3 2024 6 -$0.22 -$0.12 -$0.15
Q4 2024 2 -$0.11 -$0.11 -$0.11
Q1 2025 5 -$0.14 -$0.14 -$0.14
Q2 2025 5 -$0.16 -$0.16 -$0.16
Q3 2025 5 -$0.15 -$0.15 -$0.15
Q4 2025 5 -$0.15 -$0.15 -$0.15

Y-mAbs Therapeutics, Inc. Earnings Date And Information

Y-mAbs Therapeutics, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.21 earnings per share for the quarter, missing analysts' consensus estimates of $-0.13 by $0.08. The company had revenue of 22.80 M for the quarter and had revenue of 84.82 M for the year. Y-mAbs Therapeutics, Inc. has generated $0 earnings per share over the last year ($-0.49 diluted earnings per share) and currently has a price-to-earnings ratio of -25.33. Y-mAbs Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.

Y-mAbs Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
08/12/2024 Q2 2024 -$0.13 -$0.21 -0.08 $23.02 M $22.80 M
05/07/2024 Q1 2024 -$0.12 -$0.15 -0.03 $19.93 M
02/29/2024 Q4 2023 -$0.19 -$0.02 0.17 $23.36 M
11/13/2023 Q3 2023 -$0.16 -$0.18 -0.02 $20.97 M $20.45 M
08/10/2023 Q2 2023 -$0.24 -$0.14 0.1 $20.33 M $20.75 M
05/08/2023 Q1 2023 -$0.31 -$0.12 0.19 $20.25 M
03/30/2023 Q4 2022 -$0.44 -$0.01 0.43 $31.45 M
11/07/2022 Q3 2022 -$0.75 -$0.66 0.09 $12.01 M $12.54 M
08/08/2022 Q2 2022 -$0.68 -$0.97 -0.29 $10.80 M
05/09/2022 Q1 2022 -$0.71 -$0.65 0.06 $10.49 M
03/01/2022 Q4 2021 -$0.85 $10.77 M $9.60 M
11/04/2021 Q3 2021 -$0.60 -$0.66 -0.06 $10.87 M $8.97 M
08/09/2021 Q2 2021 -$0.53 $7.33 M $10.95 M
05/06/2021 Q1 2021 $0.61 $0.80 0.19 $5.38 M
03/01/2021 Q4 2020 -$0.48 $11.59 M $20.75 M
11/05/2020 Q3 2020 -$0.80 -$0.82 -0.02 $0
08/06/2020 Q2 2020 -$0.69 -$1.01 -0.32 $0
05/07/2020 Q1 2020 -$0.63 -$0.66 -0.03 $0
03/12/2020 Q4 2019 -$0.67 -$0.61 0.06 $0
11/13/2019 Q3 2019 -$0.54 -$0.70 -0.16 $0
 

Y-mAbs Therapeutics, Inc. Earnings: Frequently Asked Questions

  • When is Y-mAbs Therapeutics, Inc.'s earnings date?

    Y-mAbs Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.

  • How can I listen to Y-mAbs Therapeutics, Inc.'s earnings conference call?

    The conference call for Y-mAbs Therapeutics, Inc.'s latest earnings report can be listened to online.

  • How can I read Y-mAbs Therapeutics, Inc.'s conference call transcript?

    The conference call transcript for Y-mAbs Therapeutics, Inc.'s latest earnings report can be read online.

  • How much revenue does Y-mAbs Therapeutics, Inc. generate each year?

    Y-mAbs Therapeutics, Inc. (:YMAB) has a recorded annual revenue of $84.82 M.

  • How much profit does Y-mAbs Therapeutics, Inc. generate each year?

    Y-mAbs Therapeutics, Inc. (:YMAB) has a recorded net income of $84.82 M. Y-mAbs Therapeutics, Inc. has generated $-0.49 earnings per share over the last four quarters.

  • What is Y-mAbs Therapeutics, Inc.'s price-to-earnings ratio?

    Y-mAbs Therapeutics, Inc. (:YMAB) has a price-to-earnings ratio of -25.33 and price/earnings-to-growth ratio is -0.33.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.